BR0204465A - Doadores de óxido nìtrico baseados em centros metálicos - Google Patents

Doadores de óxido nìtrico baseados em centros metálicos

Info

Publication number
BR0204465A
BR0204465A BR0204465-0A BR0204465A BR0204465A BR 0204465 A BR0204465 A BR 0204465A BR 0204465 A BR0204465 A BR 0204465A BR 0204465 A BR0204465 A BR 0204465A
Authority
BR
Brazil
Prior art keywords
nitric oxide
oxide donors
metal center
center based
based nitric
Prior art date
Application number
BR0204465-0A
Other languages
English (en)
Inventor
Luigi Casella
Marina Ziche
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Publication of BR0204465A publication Critical patent/BR0204465A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Glass Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"DOADORES DE óXIDO NìTRICO BASEADOS EM CENTROS METáLICOS". A invenção refere-se a complexos de ligando caracterizados pela presença de um resíduo piperazinaNONOato com cátions de metal em que os cátions derivam de um metal de transição ou de zinco em um estado de oxidação estável. Estes complexos são doadores de óxido nítrico e exercem um efeito endotélio-protetor sobre a região das coronárias e estimula os processos de reendotelialização e de angiogênese. A invenção compreende um processo de preparação e o uso terapêutico dos ditos compostos.
BR0204465-0A 2001-03-01 2002-02-21 Doadores de óxido nìtrico baseados em centros metálicos BR0204465A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI000426A ITMI20010426A1 (it) 2001-03-01 2001-03-01 Donatori di ossido di azoto basati su centri metallici
PCT/EP2002/001839 WO2002070496A1 (en) 2001-03-01 2002-02-21 Nitric oxide donors based on metallic centres

Publications (1)

Publication Number Publication Date
BR0204465A true BR0204465A (pt) 2003-06-24

Family

ID=11447080

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0204465-0A BR0204465A (pt) 2001-03-01 2002-02-21 Doadores de óxido nìtrico baseados em centros metálicos

Country Status (13)

Country Link
US (1) US6897218B2 (pt)
EP (1) EP1370544B1 (pt)
JP (1) JP2004518757A (pt)
CN (1) CN1234698C (pt)
AT (1) ATE322488T1 (pt)
BR (1) BR0204465A (pt)
DE (1) DE60210428T2 (pt)
ES (1) ES2257538T3 (pt)
HU (1) HUP0302262A2 (pt)
IL (1) IL152555A0 (pt)
IT (1) ITMI20010426A1 (pt)
NO (1) NO324365B1 (pt)
WO (1) WO2002070496A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2731298T3 (es) 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
US7807624B2 (en) * 2006-01-11 2010-10-05 Affinergy, Inc. Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
US7531505B2 (en) * 2006-01-11 2009-05-12 Affinergy, Inc. Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
WO2007110084A1 (en) * 2006-03-27 2007-10-04 Salah Fathi Hussein Pyrazinic acid copper (i) complex
US20110136776A1 (en) * 2008-07-22 2011-06-09 Salah Fathiy Hussein Aly Ibraheim Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same
CA2771389C (en) 2009-08-21 2019-04-09 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
CN112266396B (zh) * 2020-10-10 2021-08-20 中国药科大学 一种基于生物正交化学的整合型前药、制备方法及其医药用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5389675A (en) * 1992-03-27 1995-02-14 The United States Of America As Represented By The Department Of Health And Human Services Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
US5898038A (en) 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors

Also Published As

Publication number Publication date
EP1370544A1 (en) 2003-12-17
US20040029854A1 (en) 2004-02-12
DE60210428D1 (de) 2006-05-18
WO2002070496A1 (en) 2002-09-12
ES2257538T3 (es) 2006-08-01
CN1458926A (zh) 2003-11-26
NO20025223D0 (no) 2002-10-31
EP1370544B1 (en) 2006-04-05
NO324365B1 (no) 2007-10-01
HUP0302262A2 (hu) 2003-10-28
CN1234698C (zh) 2006-01-04
JP2004518757A (ja) 2004-06-24
DE60210428T2 (de) 2006-11-23
NO20025223L (no) 2002-12-27
ATE322488T1 (de) 2006-04-15
US6897218B2 (en) 2005-05-24
ITMI20010426A1 (it) 2002-09-01
IL152555A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
BR9909730A (pt) Dihidropirimidinas
ES2060002T3 (es) Compuestos formadores de quelatos para la complejacion de isotopos radiactivos, sus complejos con metales, asi como su utilizacion en diagnostico y terapia.
BR0204465A (pt) Doadores de óxido nìtrico baseados em centros metálicos
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
BR9913890A (pt) Composição de cuidado oral, e, uso de complexos de cobre, zinco, ferro ou estanho divalente ou ferro trivalente, ligados a uma alfa-hidroxicetona cìclica
BR9910907A (pt) Compostos cìclicos de boroprolina
BR0001254A (pt) Composição que compreende pelo menos um composto bicìclico aromático, utilização da composição e processo de solubilização de um composto bicìclico aromático
ES2052570T3 (es) Preparacion de antitranspirantes.
BRPI0004827B8 (pt) complexo à base de ácido ortossilícico biologicamente assimilável, processo de preparação do mesmo, composição cosmética ou farmacêutica, e, complemento nutritivo
BR8701981A (pt) Composto de cerio iv,processos de preparacao deste composto e de um sol aquoso e sol aquoso assim obtido
DE69014717D1 (de) Stabilisierte Zusammensetzungen von Metalloxidpulver.
KR960013376A (ko) 철과 디프룩토오스를 함유하는 빈혈치료제
DE3676315D1 (de) Metallbearbeitungsfluessigkeitzusammensetzung.
DK543987A (da) Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme
DE3778869D1 (de) Korrosionsinhibierung von eisenmetallen.
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
MA24721A1 (fr) Compositions nouvelles renfermant des derives de benzopyranne et pyrydopyranne et procede pour leur preparation
BR0201415A (pt) Processo e dispositivo para produção de óxidos metálicos
EP0167936A3 (en) Use of actinonin as an immunopotentiator
FR2434870A1 (fr) Alliage jaune a base d'or pouvant etre utilise notamment comme alliage dentaire revetu eventuellement d'un materiau ceramique
MA26726A1 (fr) Composition pharmaceutique de resorcinol, et procede pour sa preparation
ATE53039T1 (de) Technetium-aren-komplexe und verfahren.
ATE240100T1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
BE903065A (fr) Nouvelles preparations pharmaceutiques
FR2758724B1 (fr) Composition topique a base de protamine pour le traitement de la cellulite et des surcharges ponderales

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.